GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Holding in Top 10
Increase
Decrease
Funds Holding
3,197
Funds Holding Change
-34
Funds Holding Growth
-1%
Value
$562B
Holding in Top 10
425
Top 10 Change
-62
Top 10 Growth
-13%
Value Growth
-5%
New
107
Increased
1,325
Reduced
1,529
Closed
101
Capital Inflow
$20.8B
Capital Outflow
$24.3B
Net Capital Flow
-$3.48B
Capital Flow Change
+$4.34B
Calls
$5.34B
Puts
$5.74B
Net Calls
-$405M
Put/Call Ratio
1.08